Santhera to present at the Biotech Showcase 2011
Santhera Pharmaceuticals (SIX: SANN) today announced that Klaus Schollmeier, Chief Executive Officer, will present at the upcoming Biotech Showcase Conference on Monday, January 10, 2011 at 2:15 p.m. Pacific Time at the Parc 55 Wyndham Union Square Hotel in San Francisco, CA.
- (1888PressRelease) January 07, 2011 - About the Biotech Showcase(TM) (Innovation - Opportunity - Collaboration):
Now in its third year, Biotech Showcase(TM) will feature corporate presentations by 195 innovative life science companies to an audience of public and private investors, business development executives and professional advisors who are interested in investment opportunities and collaboration. The showcase takes place during the week of one of the most important healthcare investor conferences which annually attracts thousands of healthcare and life science business executives to San Francisco in a venue located close to the center of action. Public and private investors are always invited to attend the showcase on a complimentary basis. The Biotech Showcase(TM) was co-founded by Demy-Colton Life Science Advisors and EBD Group, two organizations that have a long and successful history building programs that meet the needs of the life sciences industry. Visit our website for more information: www.ebdgroup.com/bts/index.php
About Santhera
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative pharmaceutical products for the treatment of severe neuromuscular diseases, an area of high unmet medical need which includes many orphan indications with no current therapy. Santhera's first product, Catena®, to treat Friedreich's Ataxia is marketed in Canada. For further information, please visit www.santhera.com
Catena® is a trademark of Santhera Pharmaceuticals.
For further information, contact
Thomas Staffelbach, Head Public & Investor Relations
Phone: +41 (0)61 906 89 47
thomas.staffelbach ( @ ) santhera dot com
Disclaimer/Forward-looking statements
This communication does not constitute an offer or invitation to subscribe for or purchase any secu rities of Santhera Pharmaceuticals Holding AG. This publication may contain certain forward-looking statements concerning the Company and its business. Such statements involve certain risks, un certainties and other factors which could cause the actual results, financial condition, performance or achievements of the Company to be materially different from those expressed or implied by such statements.
Readers should therefore not place undue reliance on these statements, particularly not in connection with any contract or investment decision. The Company disclaims any obligation to update these forward-looking statements.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam